BioSpace News Archive

Leadership Enhancements Position Company for Upcoming Regulatory Engagement and Clinical Milestones New Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs and Program Leadership

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized offering, with up to an additional $48 Million upon exercise of milestone warrants, provides potential funding through commercialization Company hosting Fireside Chat with Dr. Theodore McRackan, on February 25th at 10 a.m. ET, to discuss his initial experiences as clinical trial’s leading implanter

Naturally-Derived 5 mg Psilocybin Capsules Mark the Company’s Second Drug in Market Under Australia’s Authorised Prescriber Scheme